Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    12 days ago
    No Change Detected
  2. Check
    19 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:34:28.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The only change observed is a revision update on the page from v3.4.0 to v3.4.1, with no alteration to study details, eligibility criteria, outcomes, locations or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:26:17.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Glossary display is now shown and new metadata items were added: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T22:15:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added the new revision tag: Revision: v3.3.4. Removed the previous tag: Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T06:36:53.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a centralized 'Locations' section listing all study sites by state/province (e.g., Alabama, Arizona, Alberta, Ontario, etc.). Individual location subsections were replaced by this consolidated list.
    Difference
    1%
    Check dated 2025-12-23T21:33:53.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Minor wording change in the Publications section (about the results of the study vs about the study results) and an adjacent revision tag update (v3.3.2 vs v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:53.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.